2008 (London)
12 June PDF (50K)
A one-day symposium organised by the Joint Pharmaceutical
Analysis Group looked at methods to detect counterfeit medicines, the
current
and prospective legislative position, and ways to combat counterfeiting. Joseph
Chamberlain report
The Joint Pharmaceutical Analysis Group
symposium took place at King’s College London on 12 June
2008 (London)
3-4 April PDF (40K)
New techniques that can improve the efficiency
of pharmaceutical
analysis were discussed at a recent symposium of the Joint Pharmaceutical Analysis
Group. Joseph Chamberlain reports
The Joint Pharmaceutical Analysis Group symposium took place at the School of
Pharmacy, University of London, on 3 and 4 April
2007 (London)
13 December PDF (70K)
A recent symposium looked at the use of highly
sensitive
methods in pharmaceutical analysis. Joseph Chamberlain reports
This symposium organised by The Joint Pharmaceutical Analysis Group took place
at the School of Pharmacy, University of London, on 13 December 2007
2007 (London)
11 October PDF (40K)
Joseph Chamberlain reports on what industry
representatives think about risk assessment in analytical applications and specific
risk areas
The meeting on the involvement of the analytical sciences in risk management
was arranged by the Joint Pharmaceutical Analysis Group and held at Church House,
London, on 11 October
2007 (London)
2 May PDF (30K)
An audience of hospital pharmacists, Qualified Persons
and sponsors from the pharmaceutical industry heard presentations at a recent
meeting on how clinical trials rely on analytical support. Joseph Chamberlain
reports
The Joint Pharmaceutical Analysis Group presented this symposium on 2 May at
the Royal Pharmaceutical Society’s London headquarters
2007 (London)
22 March PDF (40K)
Material characterisation techniques play
an increasingly
central role in product and process understanding. The latest developments in
these techniques and their applications were reviewed in a recent symposium.
Joseph Chamberlain reports
The symposium, organised by the Joint Pharmaceutical Analysis Group and the Academy
of Pharmaceutical Sciences took place at the School of Pharmacy, University of
London, on 22 March
2006 (London)
7 December PDF (50K)
Industry is increasingly realising the importance
that controlling the properties of the input materials has in achieving more
reliable and efficient processes and effective products, a recent sympsium
heard.
Joseph Chamberlain reports
This symposium was organised by the Joint Pharmaceutical Analysis Group in association
with the Academy of Pharmaceutical Sciences. It took place in London on 7 December
2006
2006 (London)
15 June PDF (40K)
A recent meeting in London provided an insight into the analysis
of modified release products, including the use of dissolution testing and in
vitro–in vivo correlations. Joseph Chamberlain reports
The Joint Pharmaceutical Analysis Group in association with King’s College
London met on 15 June
2006 (London)
29 March PDF (30K)
A recent meeting examined the manufacture and control
of active pharmaceutical ingredients and included perspectives from opinion leaders
in the pharmaceutical industry and regulatory agencies. Joseph Chamberlain reports
The meeting of the Joint Pharmaceutical Analysis Group in association with King’s
College London Pharmaceutical Science Research Division took place at King’s
College London on 29 March
2005 (London)
8 December PDF (40K)
Intelligent method development: why it is important to the drug industry
Method validation is covered in scientific meetings and courses far more frequently
than is method development, yet the development phase is important because if
the method foundations are not strong, then validation can only confirm that
fact; it cannot improve the method.
Joseph Chamberlain reports from a meeting that explored best practices for the
intelligent development of informative, robust methods
The “intelligent method development” symposium, organised by The
Joint Pharmaceutical Analysis Group, took place at the Royal Pharmaceutical Society’s
London headquarters on 8 December 2005
2005 (London)
13 October PDF (60K)
Developments in NIR spectrometry in relation to pharmaceutical analysis
Practising pharmaceutical analysts specialising in near-infrared spectroscopy
gathered with regulators and teachers to examine and discuss the current state
of the art. Joseph Chamberlain reports
This one-day symposium organised by the Joint Pharmaceutical Analysis Group took
place on 13 October at the Royal Pharmaceutical Society’s London headquarters
19 May PDF (70K) The
Pharmaceutical Journal
19 May PDF (90K) Hospital
Pharmacist
One year on: what has been the impact of the
clinical trials directive?
The impact of the legislation on clinical trials was reviewed before a large
audience of representatives from the pharmaceutical industry and the National
Health Service at a recent meeting
This one-day update symposium was organised by the Joint Pharmaceutical Analysis
Group in association with the Academy of Pharmaceutical Scientists and the Royal
Pharmaceutical Society Hospital Pharmacists Group on 19 May
March 17 PDF (45K)
In a one-day update symposium the technologies and applications of charge-based separations in pharmaceutical analysis were examined by leading experts from industry, academia and the regulatory authorities. Joseph Chamberlain reports
The symposium was organised by The Joint Pharmaceutical Analysis Group and took place at the Royal Pharmaceutical Society’s London headquarters on 17 March
2004 (London)
December 2 PDF (50K)
A recent meeting heard about the various applications of genomics, proteomics and metabonomics in drug development and discovery.
Geoffrey Phillips, honorary secretary of the Joint Pharmaceutical Analysis Group, reports
This meeting on genomics, proteomics and metabonomics in drug discovery and
development was presented by the Joint Pharmaceutical Analysis Group. It took place on 2 December 2004 at the London headquarters of the Royal Pharmaceutical Society
2004 (London)
May 20 PDF (50K)
While ICH validation guidelines provide a framework for the core activity of measurement validity, actual requirements are heavily influenced by the purpose and uncertainty of the measurement. This meeting, reported by Joe Chamberlain, examined key strategies for the successful validation of analytical methods at all stages of a medicine's life, from clinical trials through to post-marketing
The one-day symposium on method
validation organised by the Joint Pharmaceutical Analysis Group took place at the Royal Pharmaceutical Society’s London headquarters on 20 May. Dr Chamberlain is a former editor of The Journal of Pharmacy and Pharmacology
2004 (London)
Mar 18 PDF (55K)
A recent meeting discussed technical and regulatory
issues surrounding the use of rapid microbiological methods and the substantial
advantages they offer to the pharmaceutical industry for product quality
control and process analytical technology. Joe Chamberlain reports
The meeting, organised by the Joint Pharmaceutical Analysis Group, took
place at the Royal Pharmaceutical Society's London headquarters on 18
March. Dr Joe Chamberlain is a former editor of The Journal of Pharmacy
and Pharmacology
2004 (London)
Feb 12-13 PDF (55K)
A recent international conference in London considered
progress towards regulatory guidance for validation of analytical methods
for the quantitation of macromolecules in biological fluids, for assessment
of antibodies and for validation of biomarker assays. Howard Hill reports
Bioval 2004 was organised by the Joint Pharmaceutical Analysis Group
(a joint venture of the Royal Pharmaceutical Society and the Royal Society
of Chemistry), and was held at the Society’s London headquarters on 12
and 13 February. Dr Hill is chairman of the meeting’s organising committee
2003 (London)
Dec 20-27 PDF (60K)
The science base underpinning pharmaceutical development
and manufacture has failed to keep pace with available technology. The
drivers, means and benefits of adopting a process analytical technology
strategy, its facilitation in the regulatory environment and its impact
on analytical science and the analyst were reviewed in a workshop held
by the Joint Pharmaceutical Analysis Group at the Royal Pharmaceutical
Society's London headquarters on 4 December. Dr Joseph Chamberlain reports
|
Joint Pharmaceutical Analysis Group Joint with RPSGB and
www.jpag.org
The Joint Pharmaceutical
Analysis Group is a focus for the presentation
and discussion of matters of importance to those interested in pharmaceutical
analysis.
The remit of the group is “to encourage, assist and extend
the knowledge and study of pharmaceutical analysis and quality control
by the holding of scientific meetings, by the promotion of lectures,
practical demonstrations and discussion, or by any means consistent
with the aims and objects of the sponsoring bodies and the with the
rules of the group”.
The group normally holds scientific meetings in January, March
(with the group’s annual general meeting), May, October and
December. The meetings are generally held on Thursdays at the Royal
Pharmaceutical
Society’s headquarters in London.
The group also encourages
joint meetings with other organisations. In some years, one or
more sessions are organised within the annual British
Pharmaceutical Conference.
The group’s sponsoring bodies
are the Royal Pharmaceutical Society and the Royal
Society of Chemistry.
Membership of the group
is open to member of either society and is free to members of the
Royal Pharmaceutical Society.
Pharmacists wishing to join the group should apply in writing,
giving their registration number, to the Secretariat, Joint Pharmaceutical
Analysis Group, Room 403, Royal Pharmaceutical Society, 1 Lambeth
High Street, London SE1 7JN
A programme of forthcoming scientific
meetings is available from the secretariat. |
|
